Compare · QUMU vs WGS
QUMU vs WGS
Side-by-side comparison of Qumu Corporation (QUMU) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both QUMU and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.61B, about 78.0x QUMU ($33.4M).
- WGS has hit the wire 8 times in the past 4 weeks while QUMU has been quiet.
- WGS has more recent analyst coverage (8 ratings vs 0 for QUMU).
- Company
- Qumu Corporation
- GeneDx Holdings Corp.
- Price
- $0.89-0.08%
- $87.40+2.58%
- Market cap
- $33.4M
- $2.61B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 8
Qumu Corporation
Qumu Corporation provides tools to create, manage, secure, distribute, and measure live and on-demand video content for the enterprises. It offers software on a license, cloud-hosted software as a service, or term software license basis; and sells third-party hardware appliances, as well as provides maintenance and support, and professional and other services. The company's platform provides video capture services; video content management services, such as creation and editing, analytics, automated workflows, security and access control, and speech search; and extensions and add-ons. It serves the banking, finance and insurance, manufacturing, services and consulting, telecom and technology, and biotech and health care markets, as well as government customers through direct sales and channel partners in North America, Europe, and Asia. The company was formerly known as Rimage Corporation and changed its name to Qumu Corporation in September 2013. Qumu Corporation was founded in 1978 and is headquartered in Minneapolis, Minnesota.
Latest QUMU
- Enghouse Releases Second Quarter Results
- SEC Form 15-12G filed by Qumu Corporation
- SEC Form SC 13G/A filed by Qumu Corporation (Amendment)
- SEC Form EFFECT filed by Qumu Corporation
- SEC Form EFFECT filed by Qumu Corporation
- SEC Form 4 filed by Lucas Kenan
- SEC Form SC 13G/A filed by Qumu Corporation (Amendment)
- SEC Form S-8 POS filed by Qumu Corporation
- SEC Form S-8 POS filed by Qumu Corporation
- SEC Form S-8 POS filed by Qumu Corporation
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026